Grifols’ Phase III AdFIrst trial met its primary endpoint and the company plans ...
Sudo Biosciences secured $30m in second round of Series B funding to further the...
A Food and Drug Administration advisory panel lent its support to Abbott's new d...
Lawmakers are considering increasing doctors’ Medicare pay in an upcoming govern...
Private equity investors made only 4 investments in Medicare Advantage-related c...
While just 2,000 Alzheimer's patients are currently taking Leqembi, an additiona...
A new study shows that people vaccinated against Ebola with a single dose of Me...
A U.S. district judge granted a Biden administration request to dismiss a PhRMA ...
A California biotech developing a combination therapy with the blockbuster obesi...
Patients with herditary angioedema may soon get a pill alternative to the inject...
A California court is setting a dangerous precedent over drug development.
Super Bowl ads are an opportunity for brands to put their work in front of more ...
A federal district judge dismissed a lawsuit challenging Medicare’s new drug pri...
Insurers are disappointed in the government's initial pitch for 2025 Medicare Ad...
South Asians are at greater risk of developing heart disease than white people, ...
A new study shows that in addition to preventing infections, the Ebola vaccine c...
